iBio, Inc. (IBIO)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 8.37M |
| Enterprise value | 21.15M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 17.82 |
| Price/book (mrq) | 0.54 |
| Enterprise value/revenue | 36.22 |
| Enterprise value/EBITDA | -0.76 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -92.94% |
| S&P500 52-week change 3 | 16.57% |
| 52-week high 3 | 4.5000 |
| 52-week low 3 | 0.2600 |
| 50-day moving average 3 | 0.3928 |
| 200-day moving average 3 | 0.8569 |
Share statistics
| Avg vol (3-month) 3 | 607.14k |
| Avg vol (10-day) 3 | 360.43k |
| Shares outstanding 5 | 27.59M |
| Implied shares outstanding 6 | 27.59M |
| Float 8 | 27.32M |
| % held by insiders 1 | 2.20% |
| % held by institutions 1 | 10.81% |
| Shares short (14 Sept 2023) 4 | 691.41k |
| Short ratio (14 Sept 2023) 4 | 0.96 |
| Short % of float (14 Sept 2023) 4 | 3.06% |
| Short % of shares outstanding (14 Sept 2023) 4 | 3.06% |
| Shares short (prior month 14 Aug 2023) 4 | 279.61k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 10 June 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:25 |
| Last split date 3 | 09 Oct 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 29 June 2023 |
| Most-recent quarter (mrq) | 29 June 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -26.08% |
| Return on equity (ttm) | -74.33% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -28.32M |
| Net income avi to common (ttm) | -29.31M |
| Diluted EPS (ttm) | -149.2700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.3M |
| Total cash per share (mrq) | 0.16 |
| Total debt (mrq) | 17.48M |
| Total debt/equity (mrq) | 113.61% |
| Current ratio (mrq) | 1.22 |
| Book value per share (mrq) | 0.76 |
Cash flow statement
| Operating cash flow (ttm) | -30.44M |
| Levered free cash flow (ttm) | -33.22M |
© 2023 Yahoo. All rights reserved.
